Menu Back toPanel discussion: Digital Transformation in Regulatory Affairs
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA Asia 2021-The Evolution Of Clinical Trials And Regulatory Science In A Post-Pandemic Digital World In Asia
Panel discussion: Digital Transformation in Regulatory Affairs
Shimon Yoshida, PhD
- Executive Director, International Labeling Group, Global Regulatory Affairs
- Pfizer Inc, United Kingdom
Tomoko Ohsawa, PhD
- Director of Office of Informatics and Management for Safety
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan
- Senior Director, Strategy and Innovation, Global Regulatory Policy
- Janssen, Spain
- Executive Vice President
- LinkDoc Technology (Beijing) Co. Ltd, China